Skip to main content
. 2015 May 5;5(1):e1041701. doi: 10.1080/2162402X.2015.1041701

Figure 3.

Figure 3.

Induction of NCRs during immunotherapy with HDC/IL-2. The box plots show the median fluorescence intensity (MFI) of NKp30 and NKp46 expression on CD56bright (A and C) and CD16+ NK cells (B and D) at indicated time points (D1 = day 1). NKp30 was induced in both NK cell subsets during cycle 1 (n = 56) and during cycle 3 (n = 48). NKp46 was significantly up-regulated on CD16+ NK cells during both cycles, while no significant induction of NKp46 was observed on CD56bright cells (Student's paired t-test).